Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment.
Saved in:
| Title: | Improvement of Refractory Chronic Actinic Dermatitis During Tofacitinib Treatment. |
|---|---|
| Authors: | Wang YJ; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and.; Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China., Hui HZ; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and.; Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China., Cheng JR; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and.; Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China., Mao H; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and.; Guizhou University of Traditional Chinese Medicine, Guiyang, People's Republic of China., Diao QC; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and., Shi BJ; Department of Dermatology, Chongqing Hospital of Traditional Chinese Medicine (Chongqing Key Laboratory of Integrative Dermatology Research; Chongqing Clinical Research Center for Dermatology), Chongqing, People's Republic of China; and. |
| Source: | American journal of therapeutics [Am J Ther] 2023 Nov-Dec 01; Vol. 30 (6), pp. e547-e548. Date of Electronic Publication: 2023 Mar 01. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9441347 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-3686 (Electronic) Linking ISSN: 10752765 NLM ISO Abbreviation: Am J Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
